MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/mej.0000000000001175

Медицинская библиотека · European journal of emergency medicine : official journal of the European Society for Emergency Medicine · 2024

Biomarkers of COVID-19 short-term worsening: a multiparameter analysis within the prospective multicenter COVIDeF cohort.

Cancella de Abreu Marta, Ropers Jacques, Oueidat Nathalie, Pieroni Laurence, Frère Corinne, Fontenay Michaela, Torelino Krystel, Chauvin Anthony, Hekimian Guillaume, Marcelin Anne-Geneviève, Parfait Beatrice, Tubach Florence, Hausfater Pierre, COVIDeF study group

СтатьяМногоцентровое исследованиеПеревод пока не подготовлен

Аннотация

BACKGROUND

During a pandemic like COVID-19, hospital resources are constrained and accurate severity triage of the patients is required.

OBJECTIVE

The objective of this study is to estimate the predictive performances of candidate biomarkers for short-term worsening (STW) of COVID-19.

DESIGN

Prospective, multicenter (20 hospitals in Paris) cohort study of consecutive COVID-19 patients with systematic biobanking at admission, during the first waves of COVID-19 in France in 2020 (COVIDeF cohort).

SETTING AND

PARTICIPANTS

Consecutive COVID-19 patients were screened for inclusion. They were excluded in presence of severity criteria defined by either an ICU admission, mechanical ventilation (including noninvasive ventilation), acute respiratory distress, or in-hospital death before sampling. Routine blood tests measured during usual care and centralized systematic measurement of creatine kinase, C-reactive protein (CRP), procalcitonin, soluble urokinase plasminogen activator receptor (suPAR), high-sensitive troponin T (TnT-hs), N terminal pro-B natriuretic peptide (NT-proBNP), calprotectin, platelet factor 4, mid-regional pro-adrenomedullin (MR-proADM), and proendothelin were performed.

OUTCOME MEASURES AND ANALYSES: The primary outcome was STW, defined by a severity criteria within 7 days. A backward stepwise logistic regression model and a 'best subset' approach were used to identify independent association, and the area under the receiving operator characteristics (AUROC) was computed.

RESULTS

Five hundred and eleven patients were analyzed, of whom 60 (11.7%) experienced STW. Median time to occurrence of a severity criteria was 3 days. At admission, lower values of eosinophils, lymphocytes, platelets, alanine aminotransferase, and higher values of neutrophils, creatinine, urea, CRP, TnT-hs, suPAR, NT-proBNP, calprotectin, procalcitonin, MR-proADM, and proendothelin were predictive of worsening. Stepwise logistic regression identified three biomarkers significantly associated with worsening: CRP [adjusted odds ratio (aOR): 1.10, 95% confidence interval (95% CI): 1.06-1.15 for a 10-unit increase, AUROC: 0.73 (0.66-0.79)], procalcitonin [aOR: 0.42, 95% CI: 0.22-0.81, AUROC: 0.69 (0.64-0.88)], and MR-proADM [aOR: 2.85, 95% CI: 1.74-4.69, AUROC: 0.75 (0.69-0.81)]. These biomarkers outperformed clinical variables except diabetes and cancer comorbidities.

CONCLUSION

In this multicenter prospective study that assessed a large panel of biomarkers for COVID-19 patients, CRP, procalcitonin, and MR-proADM were independently associated with the risk of STW.

TRIAL REGISTRATION: ClinicalTrials.gov NCT04352348.

Для цитирования: Cancella de Abreu Marta, Ropers Jacques, Oueidat Nathalie, Pieroni Laurence, Frère Corinne, Fontenay Michaela, Torelino Krystel, Chauvin Anthony, Hekimian Guillaume, Marcelin Anne-Geneviève, Parfait Beatrice, Tubach Florence, Hausfater Pierre, COVIDeF study group. Biomarkers of COVID-19 short-term worsening: a multiparameter analysis within the prospective multicenter COVIDeF cohort.. European journal of emergency medicine : official journal of the European Society for Emergency Medicine. 2024. DOI: 10.1097/mej.0000000000001175.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.